60540

Clinical Indications

• Recurrent primary hyperparathyroidism after a previous parathyroidectomy, evidenced by persistent hypercalcemia and elevated parathyroid hormone (PTH) levels.
• Persistent hyperparathyroidism (failure to achieve normocalcemia after initial surgery).
• Secondary hyperparathyroidism (e.g., due to chronic kidney disease) that has recurred or persisted despite previous surgical intervention, often with severe bone disease or calciphylaxis.
• Tertiary hyperparathyroidism following renal transplantation, with autonomous PTH secretion leading to hypercalcemia.
• Recurrence of parathyroid carcinoma.
• Symptomatic hypercalcemia (e.g., nephrolithiasis, osteopenia, neurocognitive impairment) attributable to recurrent or persistent hyperparathyroidism.

Procedure Steps

1. Preoperative imaging studies to localize abnormal parathyroid tissue, such as Sestamibi scan, ultrasound, CT, or MRI.
2. Patient positioning, sterile preparation, and draping, typically with neck hyperextension.
3. Careful re-incision along the previous surgical scar, often requiring meticulous dissection through fibrotic tissue.
4. Identification and careful dissection of recurrent or abnormal parathyroid glands, which may be located in the neck or mediastinum.
5. Intraoperative parathyroid hormone (IOPTH) monitoring to confirm successful removal of hyperfunctioning tissue.
6. Excision of identified abnormal parathyroid glands (total or subtotal parathyroidectomy).
7. If required, mediastinal exploration is performed to search for ectopic glands, often through a cervical incision or potentially a sternotomy.
8. Preparation of viable parathyroid tissue (e.g., mincing) for autotransplantation.
9. Creation of a muscle pouch (e.g., in the brachioradialis muscle of the forearm) for implantation of the prepared parathyroid tissue.
10. Implantation of the parathyroid tissue fragments into the muscle pouch.
11. Meticulous hemostasis and placement of drains if indicated.
12. Layered closure of the surgical incisions.
13. Postoperative monitoring for calcium levels and potential complications such as hypocalcemia or recurrent laryngeal nerve injury.

Coding Guidelines

• Code 60540 specifically applies to *recurrent* parathyroidectomy and *includes* autotransplantation of parathyroid tissue. If autotransplantation is not performed, code 60545 (Parathyroidectomy, total or subtotal, with or without mediastinal exploration, recurrent; without autotransplantation) should be used.
• Mediastinal exploration, if performed, is considered an integral part of this procedure and is not separately billable when performed in conjunction with 60540.
• Preoperative localization studies (e.g., ultrasound, CT, Sestamibi scan) are typically reported separately using appropriate imaging codes (e.g., 76536 for thyroid and parathyroid ultrasound, 78070 for parathyroid imaging) when medically necessary and performed independently.
• Intraoperative parathyroid hormone (IOPTH) assays (e.g., 84126) are separately billable if performed by the laboratory, but the physician's interpretation and decision-making based on IOPTH are part of the surgical management.
• This code has a 90-day global surgical period, meaning all routine pre-, intra-, and postoperative care related to the surgery for 90 days is included in the surgical fee.
• Thorough documentation is essential to support the medical necessity for a recurrent procedure, the decision for autotransplantation, and any mediastinal exploration, including operative notes detailing the findings, extent of resection, and transplantation site.

Associated ICD-10 Codes

• E21.0 - Primary hyperparathyroidism
• E21.1 - Secondary hyperparathyroidism, not elsewhere classified
• E21.2 - Other hyperparathyroidism
• C75.0 - Malignant neoplasm of parathyroid gland
• Z98.89 - Other specified postprocedural states